These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 32634286)
1. Aspirin-exacerbated respiratory disease: personalized medical and surgical approaches. Schlosser RJ Int Forum Allergy Rhinol; 2020 Sep; 10(9):1035-1036. PubMed ID: 32634286 [No Abstract] [Full Text] [Related]
2. [Aspirin-exacerbated respiratory disease: current diagnosis and treatment]. He SC; Xu YT Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2020 Nov; 55(11):1091-1094. PubMed ID: 33210895 [TBL] [Abstract][Full Text] [Related]
3. Hypereosinophilia following aspirin desensitization for aspirin-exacerbated respiratory disease. Pitlick MM; Pongdee T J Allergy Clin Immunol Pract; 2022 Aug; 10(8):2187-2190.e1. PubMed ID: 35598867 [No Abstract] [Full Text] [Related]
4. Age as a factor in treatment of aspirin-exacerbated respiratory disease: relationship to required aspirin maintenance dose after desensitization. Locke TB; Sweis AM; Gleeson PK; Lin TC; Civantos AM; Parhar HS; Corr AM; Kumar A; Salmon MK; Kohanski MA; Palmer JN; Bosso JV; Adappa ND Int Forum Allergy Rhinol; 2020 Oct; 10(10):1180-1181. PubMed ID: 32761891 [No Abstract] [Full Text] [Related]
6. COVID-19 in a series of patients with aspirin-exacerbated respiratory disease. White AA; Cahill KN; Jerschow E; Kuruvilla M; Sehanobish E; Bensko J; Laidlaw TM; Levy JM J Allergy Clin Immunol Pract; 2021 Jul; 9(7):2900-2903. PubMed ID: 33965591 [No Abstract] [Full Text] [Related]
7. The effect of aspirin desensitization on novel biomarkers in aspirin-exacerbated respiratory diseases. Katial RK; Strand M; Prasertsuntarasai T; Leung R; Zheng W; Alam R J Allergy Clin Immunol; 2010 Oct; 126(4):738-44. PubMed ID: 20728206 [TBL] [Abstract][Full Text] [Related]